See more : Prime Office A/S (PRIMOF.CO) Income Statement Analysis – Financial Results
Complete financial analysis of ONE Bio Corp. (ONBI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ONE Bio Corp., a leading company in the Biotechnology industry within the Healthcare sector.
- BF Investment Limited (BFINVEST.NS) Income Statement Analysis – Financial Results
- Hainan Development Holdings Nanhai Co., Ltd. (002163.SZ) Income Statement Analysis – Financial Results
- Autoscope Technologies Corporation (ISNS) Income Statement Analysis – Financial Results
- Caterpillar Inc. (CAT.SW) Income Statement Analysis – Financial Results
- Standard Industries Limited (SIL.BO) Income Statement Analysis – Financial Results
ONE Bio Corp. (ONBI)
Industry: Biotechnology
Sector: Healthcare
About ONE Bio Corp.
ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing the extractions of tobacco leaves and various other plant materials. It produces chemical and herbal extracts for use in a range of health and wellness products, including chemical extracts comprising Solanesol and Coenzyme Q10; and herabal extracts, such as Resveratrol, 5-Hydroxytryptophan, Ganoderma Tea, and powdered and particulate fertilizers. This business unit distributes its products through independent third party distributors, universities, and hospital research centers to the bio-health industry and raw chemical intermediates industry in the People's Republic of China. The OP business unit manufactures various consumer and commercial use health and energy drinks, organic food products, and fertilizers primarily based on bamboo in the People's Republic of China. Its products include boiled bamboo shoot cans, boiled bamboo shoot cans with vacuum packing, boiled mixed vegetables, and boiled seasoned vegetables, as well as Kamameshi, a Japanese rice dish. This segment distributes its products directly to supermarket chains, hotels, hospitals, and restaurants, as well as through a network of independent third party distributors. ONE Bio Corp. exports its products to Japan, southeast Asia, Europe, and North America. The company was formerly known as ONE Holdings, Corp. and changed its name to ONE Bio Corp. in November 2009. ONE Bio Corp. was incorporated in 2000 and is headquartered in Aventura, Florida.
Metric | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|
Revenue | 52.30M | 22.07M | 78.24K | 578.59K | 207.51K | 163.78K |
Cost of Revenue | 32.17M | 12.09M | 43.91K | 194.87K | 69.00K | 25.37K |
Gross Profit | 20.13M | 9.98M | 34.33K | 383.72K | 138.51K | 138.41K |
Gross Profit Ratio | 38.48% | 45.23% | 43.88% | 66.32% | 66.75% | 84.51% |
Research & Development | 259.88K | 378.50K | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.29M | 1.11M | 47.13K | 333.72K | 123.03K | 158.89K |
Selling & Marketing | 892.11K | 1.04M | 11.93K | 0.00 | 6.51K | 588.63 |
SG&A | 6.18M | 2.15M | 59.06K | 333.72K | 129.54K | 159.48K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 6.44M | 2.53M | 68.60K | 340.87K | 149.86K | 189.86K |
Cost & Expenses | 38.61M | 14.61M | 112.51K | 535.74K | 218.87K | 215.23K |
Interest Income | 33.34K | 36.63K | 14.14K | 0.00 | 0.00 | 0.00 |
Interest Expense | 736.41K | 230.34K | 7.87K | 7.59K | 4.59K | 3.12K |
Depreciation & Amortization | 640.30K | 637.02K | 9.01K | 4.30K | 20.26K | 29.35K |
EBITDA | 13.61M | 8.02M | -25.26K | -4.38K | 132.32K | 49.81K |
EBITDA Ratio | 27.45% | 36.84% | -32.28% | 8.15% | 4.29% | -13.49% |
Operating Income | 13.68M | 7.46M | -34.27K | 42.86K | -11.36K | -51.45K |
Operating Income Ratio | 26.16% | 33.79% | -43.79% | 7.41% | -5.47% | -31.41% |
Total Other Income/Expenses | -1.45M | -46.47K | -7.87K | -69.26K | 0.00 | 68.79K |
Income Before Tax | 12.24M | 7.41M | -42.14K | 42.86K | -3.64K | 17.35K |
Income Before Tax Ratio | 23.40% | 33.58% | -53.85% | 7.41% | -1.75% | 10.59% |
Income Tax Expense | 3.28M | 2.03M | 15.74K | 5.60K | 154.00 | 3.12K |
Net Income | 8.68M | 4.77M | -42.14K | 37.26K | -3.79K | 17.35K |
Net Income Ratio | 16.59% | 21.62% | -53.85% | 6.44% | -1.83% | 10.59% |
EPS | 1.43 | 0.95 | -0.01 | 0.01 | -0.06 | 0.25 |
EPS Diluted | 1.35 | 0.93 | -0.01 | -0.01 | -0.06 | 0.25 |
Weighted Avg Shares Out | 6.06M | 5.01M | 2.84M | 4.07M | 66.80K | 50.00K |
Weighted Avg Shares Out (Dil) | 6.42M | 5.12M | 3.04M | 4.07M | 66.80K | 50.00K |
Source: https://incomestatements.info
Category: Stock Reports